US Broker Ratings

Organon & Co. (OGN) Stock Analysis: A Closer Look at Its 31.61% Potential Upside and What It Means for Investors

Organon & Co. (OGN), a prominent player in the healthcare sector specializing in drug manufacturing, presents an intriguing opportunity for investors seeking both stability and potential upside. With a market..

Galapagos NV (GLPG) Stock Analysis: Navigating a 16% Potential Downside Amidst Biotech Innovations

Galapagos NV (Nasdaq: GLPG), a Belgium-based biotechnology firm, stands at a pivotal moment for investors keen on the healthcare sector. With a market capitalization of $2.18 billion, Galapagos is not..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a Potential 50% Upside with a High Dividend Yield

Perrigo Company plc (NYSE: PRGO), a prominent player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, presents an intriguing opportunity for investors. With its headquarters..

Concentra Group Holdings Parent (CON) Stock Analysis: A Healthcare Play with 41% Upside Potential

Concentra Group Holdings Parent, Inc. (CON), a key player in the healthcare sector, is garnering significant attention from investors seeking robust growth prospects. With a current market capitalization of $2.58..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Exploring a 50.70% Potential Upside in Gene Editing Innovations

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneering entity in the realm of gene editing, is capturing investor attention with its cutting-edge CRISPR/Cas9 technology. Operating within the biotechnology sector, this Swiss..

Kiniksa Pharmaceuticals (KNSA) Investor Outlook: Exploring a Promising 33% Upside

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) is capturing investor attention with its impressive growth potential and robust pipeline of novel therapies targeting diseases with unmet medical needs. With a current market..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: A Potential 17% Upside in the Medical Devices Sector

Alphatec Holdings, Inc. (NASDAQ: ATEC) stands out as a compelling player in the healthcare sector, specifically within the dynamic field of medical devices. The company, headquartered in Carlsbad, California, is..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Exploring a 7.47% Potential Upside in the Biotech Sector

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a prominent player in the biotechnology industry, continues to capture investor attention with its innovative therapeutic developments and significant market presence. With a current market..

CG Oncology, Inc. (CGON) Stock Analysis: Exploring a 77% Potential Upside in Biotech

For investors eyeing the biotechnology sector, CG Oncology, Inc. (NASDAQ: CGON) presents a compelling opportunity. With a market capitalization of $3.22 billion, this Irvine, California-based company specializes in developing innovative..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A 13% Upside Potential in the Booming Healthcare Plans Sector

Alignment Healthcare, Inc. (NASDAQ: ALHC) is carving a distinctive niche in the healthcare industry with its consumer-centric platform designed to cater to the needs of seniors through Medicare Advantage plans...

Viking Therapeutics, Inc. (VKTX) Stock Analysis: A Biotech Gem with 156% Upside Potential

Viking Therapeutics, Inc. (NASDAQ: VKTX) has emerged as a standout player in the biotechnology sector, capturing the attention of investors with its promising pipeline and significant upside potential. With a..

Amicus Therapeutics, Inc. (FOLD): Exploring 19.5% Revenue Growth and Analyst Consensus in the Biotech Sector

Amicus Therapeutics, Inc. (NASDAQ: FOLD), a prominent player in the biotechnology sector, has been making waves with its focus on rare diseases. As the company continues to expand its footprint..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A Biotech Force with 28.54% Potential Upside

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a prominent player in the biotechnology sector, has captured investor attention with its innovative approach to treating rare and orphan diseases. Headquartered in Foster City,..

Metsera, Inc. (MTSR) Stock Analysis: What Investors Need to Know About This Biotech with -19.15% Potential Downside

Metsera, Inc. (NASDAQ: MTSR), a subsidiary of Pfizer Inc., is a clinical-stage biotechnology company that has carved out its niche in the healthcare sector. Based in New York, Metsera focuses..

PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: A Surgical Robotics Pioneer with a 57% Upside Potential

Investors eyeing the healthcare sector should take note of PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a standout in the medical devices industry that has shown remarkable revenue growth and promising future..

Veracyte, Inc. (VCYT) Stock Analysis: Unpacking a 10.77% Potential Upside in the Diagnostics Powerhouse

Veracyte, Inc. (VCYT) stands as a notable entity in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $3.39 billion, this California-based company is..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Exploring a Massive 167% Potential Upside

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a U.S.-based biotechnology company, stands as an intriguing prospect in the healthcare sector, particularly within the niche of specialty and generic drug manufacturing. With a..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Exploring a 6.66% Potential Upside in Biotechnology

MoonLake Immunotherapeutics (MLTX) is a burgeoning player in the biotechnology sector, making waves with its innovative approach to treating inflammatory skin and joint diseases. As a clinical-stage company based in..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: A 43.92% Potential Upside Captures Investor Attention

Kymera Therapeutics, Inc. (NASDAQ: KYMR) is emerging as a compelling player in the biotechnology sector, capturing investor interest with a significant potential upside of 43.92%. The company, headquartered in Watertown,..

LifeStance Health Group (LFST) Stock Analysis: Exploring a 20% Potential Upside for Investors

LifeStance Health Group, Inc. (NASDAQ: LFST) is an intriguing player in the healthcare sector, specifically within the medical care facilities industry. Founded in 2017 and based in Scottsdale, Arizona, the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds